Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor

Familial Cancer

Volumn 10, Issue 1, 2011, Pages 141-146

  Pinto, Emilia M ^a   Ribeiro, Raul C ^a,b   Kletter, Gad B ^c   Lawrence, John P ^c   Jenkins, Jesse J ^a   Wang, Jinling ^a   Shurtleff, Sheila ^a   McGregor, Lisa ^a   Kriwacki, Richard W ^a,d   Zambetti, Gerard P ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c Swedish Pediatric Specialty Clinics   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Loss of heterozygosity; Pediatric adrenocortical tumor; Splice site mutation; TP53

Indexed keywords

PROTEIN P53;

ADRENAL CORTEX TUMOR; ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHILD; FEMALE; FRAMESHIFT MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MOTIF;

ADRENAL CORTEX NEOPLASMS; CHILD, PRESCHOOL; FEMALE; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; PROGNOSIS; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RNA SPLICE SITES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79951857698     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-010-9392-z     Document Type: Article

References (20)

1. BC Figueiredo CA Stratakis R Sandrini L DeLacerda MA Pianovsky C Giatzakis HM Young BR Haddad 1999 Comparative genomic hybridization analysis of adrenocortical tumors of childhood J Clin Endocrinol Metab 84 1116 1121 1:CAS:528:DyaK1MXhvFens7s%3D 10.1210/jc.84.3.1116 10084604 (Pubitemid 29138252)
2. A Hildesheim R Herrero J Johnson C Bratti K Bhatia IT Magrath JF Fraumeni Jr 1995 Elevated levels of p53 protein in adrenocortical carcinomas from Costa Rica Eur J Cancer 31A 125 1:STN:280:DyaK2M3gvF2guw%3D%3D 10.1016/0959-8049(94) 00465-H 7695963
3. KD Gonzalez KA Noltner CH Buzin D Gu CY Wen-Fong VQ Nguyen JH Han K Lowstuter J Longmate SS Sommer JN Weitzel 2009 Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations J Clin Oncol 27 1250 1256 1:CAS:528:DC%2BD1MXktFKhsLg%3D 10.1200/JCO.2008.16.6959 19204208
4. A Petitjean MI Achatz AL Borresen-Dale P Hainaut M Olivier 2007 TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 26 2157 2165 1:CAS:528:DC%2BD2sXjs1yqtL4%3D 10.1038/sj.onc.1210302 17401424 (Pubitemid 46536647)
5. C Cole JD Barber GJ Barton 2008 The Jpred 3 secondary structure prediction server Nucleic Acids Res 36 W197 W201 1:CAS:528:DC%2BD1cXptlKkt7w%3D 10.1093/nar/gkn238 18463136
6. AC Joerger AR Fersht 2008 Structural biology of the tumor suppressor p53 Annu Rev Biochem 77 557 582 1:CAS:528:DC%2BD1cXos1ekurc%3D 10.1146/annurev. biochem.77.060806.091238 18410249
7. JP Kruse W Gu 2009 Modes of p53 regulation Cell 137 609 622 1:CAS:528:DC%2BD1MXosVCltrs%3D 10.1016/j.cell.2009.04.050 19450511
8. JM Varley G McGown M Thorncroft GR White KJ Tricker AM Kelsey JM Birch DG Evans 1998 A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier Br J Cancer 78 1081 1083 1:CAS:528:DyaK1cXntFGgs7w%3D 10.1038/bjc.1998.631 9792154 (Pubitemid 28463986)
9. JM Varley C Attwooll G White G McGown M Thorncroft AM Kelsey M Greaves J Boyle JM Birch 2001 Characterization of germline TP53 splicing mutations and their genetic and functional analysis Oncogene 20 2647 2654 1:CAS:528: DC%2BD3MXktVWnurY%3D 10.1038/sj.onc.1204369 11420676 (Pubitemid 32525295)
10. JM Varley G McGown M Thorncroft LA James GP Margison G Forster DG Evans M Harris AM Kelsey JM Birch 1999 Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors Am J Hum Genet 65 995 1006 1:STN:280:DC%2BD3cvnsFerug%3D%3D 10.1086/302575 10486318 (Pubitemid 30462956)
11. RC Ribeiro F Sandrini B Figueiredo GP Zambetti E Michalkiewicz AR Lafferty L DeLacerda M Rabin C Cadwell G Sampaio I Cat CA Stratakis R Sandrini 2001 An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma Proc Natl Acad Sci USA 98 9330 9335 1:CAS:528:DC%2BD3MXlvFSrsLk%3D 10.1073/pnas.161479898 11481490 (Pubitemid 32743916)
12. BC Figueiredo R Sandrini GP Zambetti RM Pereira C Cheng W Liu L Lacerda MA Pianovski E Michalkiewicz J Jenkins C Rodriguez-Galindo MJ Mastellaro S Vianna F Watanabe F Sandrini SB Arram P Boffetta RC Ribeiro 2006 Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation J Med Genet 43 91 96 1:CAS:528:DC%2BD28XhtF2hs70%3D 10.1136/jmg.2004.030551 16033918 (Pubitemid 43099998)
13. Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, Hawkins C, Bouffet E, Pienkowska M, Lafay-Cousin L, Gozali A, Zhukova N, Shane L, Gonzalez I, Finlay J, Malkin D (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28:1995-2001
14. D Malkin FP Li LC Strong JF Fraumeni Jr CE Nelson DH Kim J Kassel MA Gryka FZ Bischoff MA Tainsky, et al. 1990 Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1233 1238 1:CAS:528:DyaK3MXjslSisw%3D%3D 10.1126/science.1978757 1978757 (Pubitemid 120031831)
15. M Olivier DE Goldgar N Sodha H Ohgaki P Kleihues P Hainaut RA Eeles 2003 Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype Cancer Res 63 6643 6650 1:CAS:528: DC%2BD3sXosVGgurs%3D 14583457 (Pubitemid 37322942)
16. KE Nichols D Malkin JE Garber JF Fraumeni Jr FP Li 2001 Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers Cancer Epidemiol Biomarkers Prev 10 83 87 1:CAS:528:DC%2BD3MXhtl2gsb8%3D 11219776 (Pubitemid 32172424)
17. XW Wang CC Harris 1996 TP53 tumour suppressor gene: clues to molecular carcinogenesis and cancer therapy Cancer Surv 28 169 196 1:CAS:528: DyaK2sXit1antbs%3D 8977035
18. N Almog N Goldfinger V Rotter 2000 p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53 Oncogene 19 3395 3403 1:CAS:528:DC%2BD3cXlsFOqtbw%3D 10.1038/sj.onc.1203673 10918596 (Pubitemid 30479334)
19. JM Stommel ND Marchenko GS Jimenez UM Moll TJ Hope GM Wahl 1999 A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking EMBO J 18 1660 1672 1:CAS:528:DyaK1MXisVWntrc%3D 10.1093/emboj/18.6.1660 10075936 (Pubitemid 29127078)
20. FJ Kim AA Beeche JJ Hunter DJ Chin TJ Hope 1996 Characterization of the nuclear export signal of human T-cell lymphotropic virus type 1 Rex reveals that nuclear export is mediated by position-variable hydrophobic interactions Mol Cell Biol 16 5147 5155 1:CAS:528:DyaK28XltFKjtLg%3D 8756672 (Pubitemid 26272168)